Use of New Direct-Acting Antivirals (DAAs) in Renal Transplant Patients infected with hepatitis c virus: the first experience in sub-saharan africa
| dc.contributor.author | Tsevi, Yawovi Mawufemo | |
| dc.contributor.author | Kane, Yaya | |
| dc.contributor.author | Diallo, Kalidou | |
| dc.date.accessioned | 2021-08-09T09:08:30Z | |
| dc.date.available | 2021-08-09T09:08:30Z | |
| dc.date.issued | 2017 | |
| dc.identifier.issn | 2472-1220 | |
| dc.identifier.uri | http://rivieresdusud.uasz.sn/xmlui/handle/123456789/476 | |
| dc.description.abstract | This article speaks about the using of new direct-acting antivirals (DAAs) in renal transplant patients infected with hepatitis c virus: the first experience in sub-saharan africa | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Journal of Kidney | |
| dc.relation.ispartofseries | J Kidney, an open access journal; Vol.3/No 4 | |
| dc.subject | Ivory coast | en_US |
| dc.subject | Direct-acting antivirals | en_US |
| dc.subject | Viral hepatitis C | en_US |
| dc.title | Use of New Direct-Acting Antivirals (DAAs) in Renal Transplant Patients infected with hepatitis c virus: the first experience in sub-saharan africa | en_US |
| dc.type | Article | en_US |
| dc.territoire | Région de Ziguinchor | en_US |
